A preliminary study of Patient Dignity Inventory validation among patients hospitalized in an acute psychiatric ward by Di Lorenzo, Rosaria et al.
© 2017 Di Lorenzo et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php 
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you 
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission 
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Neuropsychiatric Disease and Treatment 2017:13 177–190
Neuropsychiatric Disease and Treatment Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
177
O r i g i N a l  r e s e a r c h
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/NDT.S122423
a preliminary study of Patient Dignity inventory 
validation among patients hospitalized in an acute 
psychiatric ward
rosaria Di lorenzo1
giulio cabri2
eleonora carretti3
giacomo galli4
Nina giambalvo4
giulia rioli4
serena saraceni4
giulia spiga4
cinzia Del giovane5
Paola Ferri6
1Mental health Department, 
service of Psychiatric Diagnosis 
and Treatment in NOcsae general 
hospital, 2Private accredited 
Psychiatric hospital villa igea, 
Modena, 3Nursing home of rubiera, 
reggio emilia, 4Department of 
Diagnostic, clinical and Public health 
Medicine, University of Modena 
and reggio emilia, 5PhD statistics 
Unit, Department of Diagnostic, 
clinical and Public health Medicine, 
6Department of Diagnostic, clinical 
and Public health Medicine, 
University of Modena and reggio 
emilia, Modena, italy
Purpose: To investigate the perception of dignity among patients hospitalized in a psychiatric 
setting using the Patient Dignity Inventory (PDI), which had been first validated in oncologic 
field among terminally ill patients.
Patients and methods: After having modified two items, we administered the Italian version 
of PDI to all patients hospitalized in a public psychiatric ward (Service of Psychiatric Diagnosis 
and Treatment of a northern Italian town), who provided their consent and completed it at 
discharge, from October 21, 2015 to May 31, 2016. We excluded minors and patients with 
moderate/severe dementia, with poor knowledge of Italian language, who completed PDI in 
previous hospitalizations and/or were hospitalized for ,72 hours. We collected the demographic 
and clinical variables of our sample (n=135). We statistically analyzed PDI scores, performing 
Cronbach’s alpha coefficient and principal factor analysis, followed by orthogonal and oblique 
rotation. We concomitantly administered to our sample other scales (Hamilton Rating Scales for 
Depression and Anxiety, Global Assessment of Functioning and Health of the Nation Outcome 
Scales) to analyze the PDI concurrent validity.
Results: With a response rate of 93%, we obtained a mean PDI score of 48.27 (±19.59 SD) with 
excellent internal consistency (Cronbach’s alpha coefficient =0.93). The factorial analysis showed 
the following three factors with eigenvalue .1 (Kaiser’s criterion), which explained .80% 
of total variance with good internal consistency: 1) “Loss of self-identity and social role”, 
2) “Anxiety and uncertainty for future” and 3) “Loss of personal autonomy”. The PDI and the 
three-factor scores were statistically significantly positively correlated with the Hamilton Scales 
for Depression and Anxiety but not with other scale scores.
Conclusion: Our preliminary research suggests that PDI can be a reliable tool to assess patients’ 
dignity perception in a psychiatric setting, until now little investigated, helping professionals 
to improve quality of care and patients to accept treatments.
Keywords: dignity experience, Patient Dignity Inventory, patients hospitalized in a psychiatric 
ward, factor analysis, validation study, dignity distress measurement
Introduction
Dignity in health care setting
Dignity is a complex concept that belongs not only to many fields of knowledge such 
as philosophy, religion, medicine, law, social sciences and ethics but also to common 
sense.1,2 The meaning of dignity has changed in accordance with historical and cultural 
evolution of human societies.3,4 In the contemporary age, dignity is considered as 
a fundamental and universal human right, as the Universal Declaration of Human 
Rights (ONU 1948) states: “All human beings are born free and equal in dignity and 
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rights for participation in the common humanity, regardless 
of status, race, social status and economic, physical illness 
and/or mental”.5,6
More recently, many authors7–9 have investigated dignity 
in health care settings, highlighting that both hospital and 
community care are places at risk for dignity damage due to 
the vulnerable conditions of patients. In particular, Jacobson9 
showed that the experience of dignity can explain the mutual 
relationship between health and human rights, suggesting 
that, in modern times, dignity represents a key concept 
for good professional practice in many fields of medicine, 
particularly in palliative and long-term care.9,10 The author 
identified the following two main forms of dignity: “human 
dignity”, which represents a universal value of the human 
race, and “social dignity”, seen as the product of the inter-
action between individuals and society, with its culture and 
tradition.11 The violation of dignity can result from asymmet-
rical relationships or vulnerable conditions such as disabling 
diseases and can induce harmful consequences for patients, 
such as feelings of fear, humiliation, embarrassment, shock, 
frustration, insecurity, apathy, isolation and depression.9 
On the contrary, the safeguarding of a patient’s dignity can 
promote “a sense of well-being”, improve adherence to 
treatments and reduce the risk for institutional regression 
and dependence.12–14 Several other authors agree on the idea 
that patients’ dignity perception can be strongly conditioned 
by various factors, such as physical environment, behavior 
and habits of health care staff, therapeutic alliance, staff 
organization and autonomy of the patient.15–19
In many fields of medicine, the risk for dignity violation 
can be represented by extreme medical procedures, which 
offer increasing chances of survival at the price of conditions 
detrimental to privacy and intimacy.20 At the same time, in 
other fields, such as psychiatry, isolation, stigmatization and 
coercion are risk conditions for dignity loss.21 In this regard, 
the World Health Organization (WHO), during the “World 
Mental Health Day” (October 10, 2015), stated: “All over 
the world, thousands of people with mental health problems 
are deprived of their human rights […] being discriminated, 
stigmatized and marginalized”.22 The WHO initiative aimed 
at increasing all useful activities to ensure a dignified life 
for people with mental disorders23 arose from the need for 
an ethical framework for decision making and treatments in 
caring for vulnerable psychiatric patients.24 In fact, protecting 
the rights of people with mental disabilities by respecting 
“their dignity, and independence, and their freedom to make 
their own choices” was recently fostered by many authors.25–29 
Health care professionals have an important role “to play as 
advocates for equality, non-discrimination and justice” and 
promote dignity and respect among patients affected by a 
mental disease “on an equal basis with others”.25–28 However, 
so far only a little research is available on this topic in psy-
chiatry, as shown by a recent study that focused on dignity in 
health contexts.21 The previous studies that focused on dignity 
in mental health care were based almost exclusively on semi-
structured interviews, which investigated the staff and not 
the patients’ experience, producing limited or not exhaustive 
results.29,30 Lindwall et al,31 who interviewed members of the 
Mental Health Department of Karlstad University in Sweden, 
showed that patients’ dignity can be maintained only if pro-
fessionals work according to ethical principles and sense of 
responsibility, whereas it can be violated when therapeutic 
alliance fails and conflicts with patients are present. Skorpen 
et al,32 interviewing inpatients of a psychiatric ward of the 
University of Solna in Stockholm, found that patients’ 
individual resources are essential to preserve their personal 
identity, dignity and autonomy, particularly in situations such 
as hospitalizations that can induce dependence on others. 
Gustafsson et al33 administered interviews to the staff of a 
forensic psychiatric facility and highlighted that the preser-
vation of dignity could be achieved by an approach toward 
patients focused on “protection”, “respect” and “fraternal 
humanity”. In another study, Gustafsson et al34 showed that 
dignity in a psychiatric ward for involuntary admissions can 
be abused both due to an authoritarian behavior and neglect 
by professionals and in case of organizational problems that 
did not permit respectful conditions for patient privacy.
Patient Dignity inventory
A tool for detecting the patient’s subjective perception 
of dignity was developed by Chochinov et al, the Patient 
Dignity Inventory (PDI), in accordance with his model of 
care for terminally ill patients, called Dignity Therapy.35,36 
This approach is based on attitudes of therapeutics: attitude, 
behavior, compassion and dialog (ABCD like the emergency 
model), aimed at ensuring the preservation of a patient’s 
dignity as “an essential element in the treatment, independent 
of clinical and demographic factors”.37 After evaluating a 
wide range of physical, psychological, spiritual and exis-
tential factors, they identified three macro-areas, each one 
associated with the 25 items that formed this questionnaire: 
1) illness-related concerns that are formed by two other 
dimensions, level of independence and symptoms distress; 
2) dignity-conserving repertoire formed by two other dimen-
sions, dignity-conserving perspectives and practices; and 
3) social dignity inventory. The statistical analysis applied 
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to the PDI demonstrated excellent internal consistency; the 
test–retest procedure showed a high degree of coherence; at 
factor analysis, a five-factor solution, which accounted for 
58% of the overall variation, was obtained.36 The concurrent 
validity of different factors was tested with different psycho-
metric instruments that measured many dimensions such as 
suffering, well-being, depression, anxiety and quality of life 
items.36 Successively, a study analyzed the construct of per-
sonal dignity, assessing the validity of the PDI items in a large 
cohort of people at the end of life in the Netherlands.38
The PDI was validated in its Italian version in the oncol-
ogy field, where it showed a good internal consistency 
(Cronbach’s alpha coefficient =0.96) with a one-factor solu-
tion that explained 48% of variance.39 Later, it was validated 
in its German40 and Spanish41 versions in oncologic care 
contexts. The German study of validation highlighted a 
four-factor solution, accounting for 71% of the overall 
variance: Loss of Sense of Worth and Meaning, Anxiety 
and Uncertainty, Physical Symptom Distress and Body 
Image, and Loss of Autonomy with high internal con-
sistencies ranging from Cronbach’s alpha 0.80–0.95.40 
Statistically significant positive associations between PDI 
scales and concurrent measures of distress (Generalized 
Anxiety Disorder 7-item scale, Beck Hopelessness Scale and 
Demoralization Scale) and significant negative correlation 
with the European Organisation for Research and Treat-
ment of Cancer Quality of Life Questionnaire-Core were 
evidenced by the German study.40 The Spanish study of PDI 
validation indicated excellent reproducibility and obtained 
a three-factor solution at factor analysis that accounted 
for 79.4% of the variance: Psychological and Existential 
Distress, Physical Symptoms and Dependency, and Social 
support.41 The Spanish authors correlated PDI with other 
scales, Edmonton Symptom Assessment System, Hospital 
Anxiety and Depression Scale and Functional Assessment 
of Chronic Illness Therapy-Spiritual Well-Being instru-
ments, highlighting positive significant relationship with the 
symptom scales and a negative significant correlation with 
the functioning scale.41 The PDI was also administered to 
patients hospitalized in an Iranian intensive cardiology unit, 
where it again showed good validity and reliability in assess-
ing patient dignity perception.42 The Iranian study evidenced 
a four-factor solution, labeled Loss of Human Dignity, 
Emotional Distress and Uncertainty, Changes in Ability and 
Mental Picture and Loss of Independence, with high internal 
consistence (the Cronbach’s alpha for PDI was 0.85 and for 
each factor ranged from 0.80 to 0.91).42 To determine con-
struct validity, the Iranian study correlated the PDI scores 
with Beck Anxiety Inventory, Beck Depression Inventory, 
Beck Hopelessness Scale and SF-36 Health Survey, high-
lighting a significant positive correlation between the overall 
score of the PDI and the factors obtained with the Beck scales 
for anxiety and depression and a negative correlation with 
SF-36 Health Survey.
These results were further developed in recent research43 
among in- and outpatients affected by non-oncologic but 
terminal conditions, which highlighted similar loss of dignity, 
ranged from moderate to severe, among the study populations 
affected by different disorders. These data suggest the 
universal psychometric properties of PDI in evaluating dig-
nity of patients coming from different cultures and suffering 
from different pathologies.
The use of PDI in a field totally different from that for 
which it was developed and validated can be justified not only 
by heuristic aims, which are, however, desired by the author 
of the questionnaire,36 but also by similar dignity issues 
shared by neoplastic and other disorders, which, especially 
if severe, can represent risk conditions for dignity loss due to 
dramatic disruption of life conditions. In this regard, the five 
domains investigated by PDI belong to stressful conditions 
related to most serious and disabling illness, as some recent 
studies have highlighted in different fields of medicine.42,43 
In psychiatry, the importance of being able to measure 
dignity stems from the need to ensure respectful treatments 
in conditions where the boundaries between individual 
rights and the public interest may conflict.21 In particular, 
the need for having their dignity respected can be felt by 
inpatients involuntarily hospitalized in a psychiatric ward 
due to acute and sometimes extreme situations, such as 
unavoidable danger for the patients themselves and others. 
In these conditions, patients can feel their privacy and 
freedom being violated, experiencing a catastrophic change 
in their life. Moreover, the hospitalization in psychiatry, 
although necessary, can frequently induce behavioral regres-
sion and institutional dependency, both risk conditions for 
dignity loss.44,45 Up to now, although there is the need for 
investigating dignity among patients affected by psychiatric 
disorders, no instrument for assessing dignity has been tested 
in psychiatry.
aim of the study
The objective of this preliminary research is to validate the 
Italian version of the PDI in an acute psychiatric ward in 
order to assess the validity of this instrument in measur-
ing the perception of dignity among inpatients affected by 
psychiatric disorders.
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Patients and methods
study design and procedures
This research is an experimental study on the use of PDI 
in a group of patients affected by psychiatric disorders and 
hospitalized in an acute ward. The questionnaire, originally 
developed by Prof HM Chochinov et al36 in 2008, consists of 
25 items evaluated on a five-solution scale ranging from “It is 
not a problem”, equivalent to a score of 1, to “It’s a problem 
that overwhelms me”, associated with the maximum score of 5. 
The total PDI score is ranged between 25 and 125 points.
After an interactive discussion among researchers, we 
adopted the Italian version of PDI, initially validated in the 
oncologic field,39 slightly modifying only two items:
•	 No 3: “Physically distressing symptoms” was changed 
to “Experiencing physically distressing symptoms (such 
as pain, shortness of breath, nausea) as drug adverse 
effects”
•	 No 17: “Concerns regarding spiritual life” was changed 
to “Concern that my spiritual life is not meaningful”.
Item No 3 was changed since physically distressing 
symptoms are not the most causes of distress or discomfort 
among patients affected by psychiatric diseases, unlike 
other organic disorders, as clinical experience suggests. 
Items No 17 was changed in order to avoid the connotation 
of end-of-life conditions present in the original version, not 
appropriate in a psychiatric setting.
We concomitantly administered additional scales in 
order to evaluate the concurrent validity with the PDI by 
validated measures of the main domains of the questionnaire 
(distress, demoralization, anxiety, depression, hopeless-
ness, functional aspects of life), as indicated by the author 
of PDI and as adopted in other studies on validation of the 
questionnaire:36,40
•	 Hamilton Rating Scale for Depression (Ham-D), a 
multiple-item questionnaire designed for adults, aimed 
at rating severity of depression, investigating mood, 
feelings of guilt, suicide ideation, insomnia, agita-
tion or retardation, anxiety, weight loss and somatic 
symptoms. It is considered the “gold standard” for 
rating depression in clinical research. The total score 
of 17 items is classified into: 0–7=	Normal; 8–13=	
Mild; 14–18=	Moderate; 19–22=	Severe; .23=	Very 
Severe Depression;46 Hamilton Anxiety Rating Scale 
(Ham-A), widely used by clinicians, is composed of 
14 items designed to evaluate the severity of anxiety, 
assessing many symptoms related to anxiety rated on 
a scale ranged from zero (the least severe) to four (the 
most severe).47
•	 Global Assessment of Functioning (GAF) is a numeric scale 
aimed at subjectively rating the social, occupational and 
psychological functioning, with a score ranged from 100 
(extremely high functioning) to 1 (severely impaired).48
These scales were chosen because they are easy and 
commonly used in psychiatry. Moreover, we evaluated the 
correlation of PDI with the Health of the Nation Outcome 
Scales (HoNOS),49 which is used in our ward at the admission 
and discharge of patients, according to local guidelines. It is 
a clinician-rated instrument comprising 12 simple scales 
measuring behavior, impairment, symptoms and social 
functioning for adult patients.
The PDI was self-administered by all patients, except one 
who was helped for visual difficulties.
The PDI questionnaire was given to hospitalized patients 
by ward medical staff in a period ranging from 3 days before 
to the time of patient discharge.
Data collection was conducted between October 21, 2015 
and May 31, 2016.
Participants
We decided that the minimum sample size for performing 
factor analysis was represented by the number of subjects 
larger by five times the number of variables, according to 
“the rule of 5” concerning the subjects-to-variables (STV) 
ratio.50,51
The sample was collected among all patients admitted 
to the acute public psychiatric ward, Service of Psychiatric 
Diagnosis and Treatment (SPDT), of a northern Italian town. 
This 15-bed ward, as required by Law 180 of 23/05/1978 
(later included in Law 833 of 12/23/1978), is located in a 
General Hospital and caters for patients with acute mental 
disorders requiring hospital care in voluntary and involun-
tary treatment from the related catchment areas (~500,000 
inhabitants). SPDT is the inpatient care facility, closely 
connected to outpatient care of both Mental Health Service 
and Substance Use Service. At discharge, most patients are 
sent to outpatient services for continuing care programs. 
However, because only short hospitalizations are allowed in 
SPDT, those patients who need to prolong inpatient voluntary 
treatment are transferred to other psychiatric wards in private 
hospitals affiliated with Mental Health Service, as mandated 
by the regional Mental Health Organization Protocol.
We collected our sample according to inclusion and 
exclusion criteria.
Inclusion criteria: all patients should be
•	 able to understand the questionnaire,
•	 able to complete it autonomously,
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•	 able to give us their informed written consent,
•	 hospitalized .72 hours and having never completed the 
questionnaire before.
Exclusion criteria:
•	 Minor age
•	 Moderate or severe mental retardation
•	 Dementia with severe cognitive impairment (Minimal 
Mental State Examination ,24)52
•	 Poor knowledge of Italian language
•	 PDI compilation in previous hospitalizations
•	 Hospitalization ,72 hours
We collected demographic and clinical variables of our 
sample from SPDT medical records, the electronic database 
used in the ward (Hospital Information System), and, when 
necessary, information was provided by each patient’s refer-
ring psychiatrists.
Demographic variables included gender, age, nationality, 
marital status, education, work activity, family and living 
conditions and social and economic conditions.
Clinical variables included psychiatric illness duration, 
psychiatric hospitalizations in the previous 10 years, psychiatric 
diagnosis at discharge (International Classification of 
Diseases, 9th Revision, Clinical Modification [ICD-9-CM]),53 
organic comorbidity, substance abuse, duration and state of 
hospitalization and destination at discharge.
This research was conducted according to the principles 
of the Declaration of Helsinki and according to good clinical 
practice. We obtained the approval for this study from 
the local ethics committee (Comitato Etico Provinciale di 
Modena Azienda Ospedaliero-Universitaria di Modena) on 
October 21, 2015 (3565 Protocol 173/15 Practice) and the 
authorization of our Department of Mental Health. A writ-
ten informed consent was one of the criteria for inclusion 
in this study.
Validity
We previously assessed the PDI content and face validity. 
The content validity was discussed among the researchers, 
who concluded that the dimensions investigated by the PDI 
can also be shared by patients affected by psychiatric dis-
eases, especially if severe and hospitalized; later, we asked 
Prof HM Chochinov his opinion about the implementation 
of this questionnaire in psychiatry, obtaining his approval. 
The face validity was initially assessed by the first 20 patients 
of our sample: we evaluated their capacity to understand the 
questionnaire and the level of difficulty in comprehending 
the concept of dignity, independently from their educational 
levels and disorders’ specificity. Since these aspects 
resulted good, we decided to continue with our validation 
study. To assess the structural validity, we investigated the 
internal consistency of PDI and explored its dimensions by 
factor analysis.54
statistical analysis
Descriptive statistical analysis was performed for demo-
graphic and clinical variables: mean ±	standard deviation 
(SD) and paired and unpaired t-test for continuous data; 
percentages and chi-square for categorical data.
The internal consistency of the PDI was evaluated by the 
Cronbach’s alpha coefficient.55 We evaluated the internal 
structure of the PDI using the conventional approach of 
principal factor analysis followed by orthogonal rotation 
(varimax), which assumed that the factors in the analysis are 
uncorrelated.56,57 The factors highlighted by the orthogonal 
rotation were selected according to the eigenvalue .1 for 
each factor (Kaiser’s criterion),58 later confirmed by the scree 
plot graphical feedback.
The items with factor loadings .0.40 on a given dimen-
sion were identified as good indicators of each factor. To 
verify the appropriateness of the orthogonal rotation analysis, 
we applied the oblique rotation of the factors (promax), which 
allowed the assessment of the factors’ interdependence, 
assuming that the factors were correlated.
To assess the appropriateness of our sample for doing 
factor analysis, we applied the Kaiser–Meyer–Olkin 
(KMO) measure, which evaluates the sampling adequacy 
in numerosity, and the Bartlett’s test of sphericity, which 
tests whether the data come from normal distribution with 
zero covariances.59
The PDI concurrent validity was analyzed by means of 
the correlation with all other scale scores (Spearman and 
Kendall tests).
Similarly, to examine internal consistency and concurrent 
validity of each factor previously identified, we calculated 
the Cronbach’s alpha coefficient for each factor and analyzed 
the correlation with all other scale scores.
Data were analyzed using STATA version 12.60
Results
In our study, the response rate to PDI was 93% since it was 
administered to 145 patients admitted to our ward but 10 of 
them (7%) refused to participate in the research.
Our sample was composed of 135 patients, 70 females 
(52%) and 65 males (48%), with an STV ratio of 5.4. 
The demographic variables are shown in Table 1. Our 
patients presented a mean age of 43.30±14.42 years, were 
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prevalently Italians (88%), single (59%), unemployed 
(44%) and had attended high school (41%), with the fol-
lowing statistically significant differences between the two 
genders: males more frequently were single (71%) and 
lived with their family of origin (54%), whereas females 
more often were married (29%) (Pearson’s χ2 =11.24, 
P=0.010) and lived with their acquired family (39%) 
(Pearson’s χ2 =15.12, P=0.002).
A descriptive analysis of the clinical variables is 
reported in Table 2. Our patients more prevalently suffered 
from schizophrenia disorders and other psychoses (43%) 
from a long period (9.38±9.34 years on average). The 
abuse substance comorbidity was statistically significantly 
prevalent among males in comparison to females (Pearson’s 
χ2=4.62, P=0.032). The most prevalent state of treatment was 
voluntary (53%) with a statistically significant prevalence 
among females (Pearson’s χ2=4.78, P=0.029). The mean 
GAF score (72.37±14.81 SD) indicated that our sample was 
composed of patients with a discrete degree of autonomy and 
functioning. The difference between the HoNOS scores at 
admission (24.10±8.33 SD) and at discharge (17.16±6.43 
SD) was statistically significant (t=7.65, P=0.000, paired 
t-test), indicating an overall clinical improvement of patients 
at discharge.
Regarding the administration of the PDI, all patients 
found it easy to read and to complete it autonomously, but 
one patient who required assistance in reading and compila-
tion of PDI due to vision problems.
Our results showed a total PDI mean score of 48.27 
(±19.59 SD), with single-item score rated an average 
value inferior to 3, as shown in Table 3. The 25 items 
of the PDI showed excellent internal consistency with a 
Cronbach’s alpha coefficient equal to or greater than 0.93 
for both individual item and total score of PDI (Table 3). 
At our exploratory factor analysis, we obtained the ini-
tial factors (the largest 10 factors are summarized with 
their eigenvalues and percentage of variance in Table 4). 
Table 1 Descriptive of demographic variables
Variables Males
n=65
(48%)
Females
n=70
(52%)
Total
n=135
(100%)
age (m ±	sD)
Years 42.90±15.32 43.67±13.64 43.30±14.42
Nationality, n (%)
italian 56 (86) 62 (89) 118 (88)
european extra-italian 1 (2) 1 (1) 2 (1)
extra-european 8 (12) 7 (10) 15 (11)
Marital status, n (%)
single 46 (71) 33 (47) 79 (59)
Married 15 (23) 20 (29) 35 (26)
Divorced/widowed 4 (6) 17 (24) 21 (15)
schooling, n (%)
Primary school 9 (14) 8 (11) 17 (12)
secondary school 23 (35) 21 (30) 44 (33)
high school 27 (42) 28 (40) 55 (41)
Degree 6 (9) 13 (19) 19 (14)
Work activity, n (%)
employed 21 (32) 24 (34) 45 (33)
Unemployed 34 (52) 26 (37) 60 (44)
retired 5 (8) 12 (17) 17 (13)
Others 5 (8) 8 (11) 13 (10)
Family and surrounding, n (%)
single 14 (22) 25 (36) 39 (29)
Parental family 35 (54) 16 (23) 51 (38)
Marital family 13 (20) 27 (39) 40 (30)
community/
residential facility
3 (5) 2 (3) 5 (3)
social and economic condition, n (%)
Sufficient 55 (85) 58 (83) 113 (84)
Insufficient 10 (15) 12 (17) 22 (16)
Abbreviations: m, mean; sD, standard deviation.
Table 2 Descriptive of clinical variables
Variables Males
n=65  
(48%)
Females
n=70  
(52%)
Total
n=135  
(100%)
Psychiatric illness duration (m ±	sD)
Years 9.17±9.72 9.58±9.03 9.38±9.34
Psychiatric hospitalizations in the previous 10 years (m ±	sD)
Number 2.53±3.67 2.75±2.68 2.65±3.19
Psychiatric diagnosis at discharge (icD-9-cM), n (%)
schizophrenic and other 
psychotic disorders
25 (38) 33 (47) 58 (43)
Bipolar disorders, manic 
episode
12 (18) 12 (17) 24 (18)
Depressive disorders 9 (14) 8 (11) 17 (12)
Personality disorders 17 (26) 14 (20) 31 (23)
Others 2 (3) 3 (4) 5 (4)
Organic comorbidity, n (%)
Present 25 (38) 26 (37) 51 (38)
absent 40 (62) 44 (63) 84 (62)
substance abuse, n (%)
Present 26 (40) 16 (23) 42 (31)
absent 39 (60) 54 (77) 93 (69)
Duration of hospitalization (m ±	sD)
Days 13.04±9.7 16±14.39 14.57±12.41
state of hospitalization, n (%)
iT 24 (37) 39 (56) 63 (47)
VT 41 (63) 31 (44) 72 (53)
Destination at discharge, n (%)
home 39 (60) 45 (64) 84 (62)
Transfer to private 
hospital
21 (32) 20 (29) 41 (30)
Transfer to community 
or residential facilities
5 (8) 5 (7) 10 (8)
Abbreviations: m, mean; sD, standard deviation; icD-9-cM, international 
Classification of Diseases, 9th Revision, Clinical Modification; IT, involuntary treat­
ment; VT, voluntary treatment.
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Successively, from the initial factors, we selected the 
first three factors that explained .80% of the cumulative 
variance, with an eigenvalue .1 according to the Kaiser’s 
criterion, and a significant discontinuity from the following 
factors at scree plot (Figure 1). At the orthogonal rota-
tion (varimax), the items that underlie the three factors 
with factor loadings .0.40 and uniqueness ,0.70 were 
chosen (Table 5). Among items that presented factor load-
ings .0.40 on more than one factor (Nos 7, 9, 11, 12, 19, 
24 and 25), we choose those with the highest factor load-
ing to identify the factor supported, as shown in Table 5. 
From our model, item Nos 3 (“Addressing physically 
disturbing symptoms resulting from side effects of drugs”) 
and 22 (“Do not feel the support of health workers”) were 
excluded because they did not support any factor, showing 
factor loading ,0.40 (low relevant in defining the factor’s 
dimensionality) and uniqueness .0.70 (low relevant in the 
factor model since the variance of these items was greatly 
shared with others) (Table 5). This result was further con-
firmed by the item–scale correlations of item Nos 3 and 22, 
which were the lowest among all the PDI items, as shown 
in Table 3. The three factors, labeled as follows, showed 
good internal consistency as measured by Cronbach’s alpha 
coefficient (Table 5):
Factor 1: Loss of self-identity and social role (Cronbach’s 
alpha coefficient =0.89), loaded by 13 items:
10. Not being able to continue with my usual routines
Table 3 PDI score, inter­item correlations and Cronbach’s alpha coefficient in our sample
PDI items Mean ±	SD Min–Max Item–test 
correlation
Cronbach’s 
alpha coefficient
 1 Not being able to carry out tasks associated with daily 
living (eg, washing myself, getting dressed)
1.54±1.09 1–5 0.4638 0.9350
 2 Not being able to attend to my bodily function 
independently (eg, needing assistance with toileting-related 
activities)
1.39±0.89 1–5 0.4671 0.9350
 3* experiencing physically distressing symptoms (such as pain, 
shortness of breath, nausea) as drug adverse effects
1.98±1.18 1–5 0.4378 0.9354
 4 Feeling that how I look to others has changed significantly 1.88±1.20 1–5 0.6008 0.9329
 5 Feeling depressed 2.33±1.44 1–5 0.6247 0.9326
 6 Feeling anxious 2.26±1.34 1–5 0.6245 0.9326
 7 Feeling uncertain about my illness and treatment 1.91±1.17 1–5 0.6523 0.9322
 8 Worrying about my future 2.57±1.45 1–5 0.6413 0.9324
 9 Not being able to think clearly 1.84±1.25 1–5 0.7205 0.9311
 10 Not being able to continue with my usual routines 2.19±1.39 1–5 0.5357 0.9340
 11 Feeling like i am no longer who i was 1.78±1.16 1–5 0.7300 0.9309
 12 Not feeling worthwhile or valued 1.90±1.20 1–5 0.7056 0.9314
 13 Not being able to carry out important roles (eg, spouse, 
parent)
2.05±1.44 1–5 0.6835 0.9317
 14 Feeling that life no longer has meaning or purpose 1.85±1.21 1–5 0.7166 0.9312
 15 Feeling that i have not made a meaningful and lasting 
contribution during my lifetime
2.19±1.29 1–5 0.7814 0.9301
 16 Feeling I have “unfinished business” (eg, things left unsaid, 
or incomplete)
2.34±1.30 1–5 0.6435 0.9323
 17* concern that my spiritual life is not meaningful 1.57±1.06 1–5 0.5126 0.9343
 18 Feeling that i am a burden to others 2.20±1.45 1–5 0.6518 0.9322
 19 Feeling that i don’t have control over my life 2.11±1.39 1–5 0.7977 0.9298
 20 Feeling that my illness and care needs have reduced my 
privacy
1.91±1.24 1–5 0.5859 0.9332
 21 Not feeling supported by my community of friends and 
family
1.90±1.23 1–5 0.6024 0.9330
 22 Not feeling supported by my health care providers 1.54±1.00 1–5 0.4194 0.9357
 23 Feeling like I am no longer able to mentally “fight” the 
challenges of my illness
1.70±1.12 1–5 0.6842 0.9317
 24 Not being able to accept the way things are 1.96±1.28 1–5 0.6750 0.9318
 25 Not being treated with respect or understanding by others 1.89±1.24 1–5 0.6735 0.9319
Total 48.27±19.59 25–125 – 0.9351
Note: *Items modified.
Abbreviations: PDi, Patient Dignity inventory; sD, standard deviation; Min, minimum; Max, maximum.
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12. Not feeling worthwhile or valued
13. Not being able to carry out important roles (eg, 
spouse, parent)
14. Feeling that life no longer has meaning or purpose
15. Feeling that I have not made a meaningful and lasting 
contribution during my lifetime
16. Feeling I have “unfinished business” (eg, things left 
unsaid, or incomplete)
17. Concern that my spiritual life is not meaningful
18. Feeling that I am a burden to others
19. Feeling that I don’t have control over my life
20. Feeling that my illness and care needs have reduced 
my privacy
21. Not feeling supported by my community of friends 
and family
23. Feeling like I am no longer able to mentally “fight” 
the challenges of my illness
25. Not being treated with respect or understanding by 
others
Factor 2: Anxiety and uncertainty for future (Cronbach’s 
alpha coefficient =0.86), loaded by seven items:
 4. Feeling that how I look to others has changed 
significantly
 5. Feeling depressed
 6. Feeling anxious
 7. Feeling uncertain about my illness and treatment
 8. Worrying about my future
 11. Feeling like I am no longer who I was
 24. Not being able to accept the way things are
Factor 3: Loss of personal autonomy (Cronbach’s alpha 
coefficient =0.78), loaded by three items:
1. Not being able to carry out tasks associated with daily 
living (eg, washing myself, getting dressed)
2. Not being able to attend to my bodily function 
independently (eg, needing assistance with toileting-
related activities)
9. Not being able to think clearly.
We obtained a value of 0.87 at the KMO test (range 
between 0 and 1), which permitted us to define our sample 
“meritorious”, since it was numerically adequate for factor 
analysis. Bartlett’s test of sphericity (Chi-square =1,732.56; 
df=300; P=0.000) showed that items were not inter-
correlated.
The oblique rotation substantially confirmed the orthogo-
nal rotation results, suggesting that the same three main factors 
were positively and partially related to each other (Table 6).
The analysis of concurrent validity showed a statisti-
cally significant positive correlation between the total score 
of the PDI and its three factors and the Ham-A and Ham-D 
scale scores, but not with other scales, as shown in Table 7, 
indicating that the dimensions investigated by PDI and other 
validated scales consisted of depression and anxiety. In our 
sample, HAM-D and Ham-A scores indicated mild to moder-
ate severity of anxiety and depression as well as PDI score, 
which showed similar degree of dignity loss.
Discussion
Our sample, despite suffering mostly from chronic and severe 
disorders, showed a good response rate (93%), confirming 
the comprehensibility and applicability of the questionnaire 
to psychiatric setting as well as to other settings different 
from the oncologic field.42,43
Our research confirmed the reliability and excellent 
internal consistency of the PDI also when implemented 
in psychiatry, as evidenced by a value of Cronbach’s 
Table 4 initial factor loading for the PDi
Initial factors Eigenvalues Proportion Cumulative
Factor 1 9.82 0.64 0.64
Factor 2 1.53 0.1 0.73
Factor 3 1.14 0.07 0.81
Factor 4 0.86 0.05 0.86
Factor 5 0.61 0.04 0.90
Factor 6 0.61 0.04 0.90
Factor 7 0.53 0.03 0.97
Factor 8 0.40 0.02 1.00
Factor 9 0.37 0.02 1.02
Factor 10 0.32 0.02 1.05
Abbreviation: PDi, Patient Dignity inventory.
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Figure 1 scree plot of the factorial analysis: eigenvalues of the PDi items.
Abbreviation: PDi, Patient Dignity inventory.
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alpha coefficient (0.93) similar to that obtained in most 
validation studies.36,39–43 The factor analysis revealed three 
factors that overlapped most dimensions identified by all 
other validation studies,36,41–43 with the exception of the Italian 
study that identified only one significant factor.39 Factor 1 
was composed of the greatest number of items with the high-
est internal consistence and included items related to the 
maintenance of both self-identity and social role, indicating 
that individual and social aspects of dignity can be violated 
in distress situations such as a severe disease. We suggested 
that our Factor 1, “Loss of self-identity and social role”, 
overlapped almost completely three factors of the Chochinov 
validation study,36 Existential Distress, Peace of Mind and 
Social Support, Factors 1 (Psychological and Existential 
Distress) and 3 (Social Support) of the Spanish validation 
study,41 and was almost completely similar to Factor 1 
(Loss of Sense of Worth and Meaning) of both the German40 
Table 5 rotated factor loadings and unique variances in the PDi factorial analysis
Items Factor 1
“Loss of self-identity 
and social role”
Factor 2
“Anxiety and 
uncertainty for future”
Factor 3
“Loss of personal 
autonomy”
Uniqueness
 1 Not being able to carry out tasks associated 
with daily living
0.0793 0.0321 0.8283 0.3067
 2 Not being able to attend to my bodily 
function independently
0.1011 0.1871 0.8033 0.3094
 3* experiencing physically distressing symptoms 
as drug adverse effects
0.1206 0.3599 0.3376 0.7419
 4 Feeling that how i look to others has changed 
significantly
0.2000 0.5264 0.3025 0.5914
 5 Feeling depressed 0.1893 0.7840 0.0394 0.3479
 6 Feeling anxious 0.1700 0.8044 0.1030 0.3135
 7 Feeling uncertain about my illness and 
treatment
0.4673 0.4836 0.2180 0.5001
 8 Worrying about my future 0.3844 0.5700 0.0681 0.5227
 9 Not being able to think clearly 0.4348 0.2992 0.5345 0.4357
 10 Not being able to continue with my usual 
routines
0.4955 0.1358 0.1125 0.7234
 11 Feeling like i am no longer who i was 0.4092 0.4944 0.3125 0.4904
 12 Not feeling worthwhile or valued 0.4953 0.4229 0.2323 0.5218
 13 Not being able to carry out important roles 
(eg, spouse, parent)
0.4501 0.3312 0.3162 0.5878
 14 Feeling that life no longer has meaning 
or purpose
0.6446 0.3913 0.1182 0.4174
 15 Feeling that i have not made a meaningful and 
lasting contribution during my lifetime 
0.7538 0.3984 0.0869 0.2655
 16 Feeling I have “unfinished business”  
(eg, things left unsaid, or incomplete)
0.5583 0.3026 0.2011 0.5563
 17* concern that my spiritual life is not 
meaningful
0.5716 0.0656 0.0430 0.6672
 18 Feeling that i am a burden to others 0.4143 0.3836 0.2904 0.5968
 19 Feeling that i don’t have control over my life 0.5581 0.5385 0.3327 0.2878
 20 Feeling that my illness and care needs have 
reduced my privacy
0.4493 0.2601 0.2710 0.6570
 21 Not feeling supported by my community of 
friends and family
0.5846 0.0381 0.3141 0.5582
 22 Not feeling supported by my health care 
providers
0.3592 0.0182 0.3280 0.7631
 23 Feeling like i am no longer able to mentally 
“fight” the challenges of my illness
0.6882 0.3595 0.0483 0.3948
 24 Not being able to accept the way things are 0.4163 0.5470 0.2212 0.4785
 25 Not being treated with respect or 
understanding by others
0.5775 0.1247 0.4351 0.4616
Notes: *Items modified. Items in bold: .0.40 factor loading; items in italic: .0.70 uniqueness.
Abbreviation: PDi, Patient Dignity inventory.
Table 6 correlation matrix of the promax rotated common 
factors
Factors Factor 1 Factor 2 Factor 3
Factor 1 1
Factor 2 0.576 1
Factor 3 0.565 0.432 1
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and the Iranian studies42 (Loss of Human Dignity). In these 
two last validation research, Factor 1 was supported by the 
highest number of items and presented good-to-excellent 
internal consistence as well as in our study.
Our Factor 2, “Anxiety and uncertainty for future”, 
presented the psychological aspects related to illness, such 
as anxiety, depression, uncertainty for future, helpless-
ness and hopelessness. It overlapped the Factor Symptom 
Distress (with the exception of the item related to physical 
symptoms) and some items of Existential Distress of the 
Chochinov validation study, some items of Factor 1 of the 
Spanish study, Psychological and Existential Distress, almost 
completely Factor 2 of the German study, which shared the 
same label and Factor 2 of the Iranian study, Emotional 
Distress and Uncertainty.
Our Factor 3, “Loss of personal autonomy” completely 
overlapped Dependency (with the exception of one item 
of Symptom Distress) among the factors identified in the 
Chochinov study and Factor 3 of both the German and the 
Iranian studies, whose labels were similar. Differently, in 
the Spanish validation study, the items that supported our 
Factor 3 presented higher factor loadings in Factor 2, Physical 
Symptoms and Dependence.
The items related to somatic concerns (“the tolerance of 
the side effects of drugs”) and the health care professional 
support (“do not feel the support of health workers”) did not 
load any factor in our analysis. This result, which is differ-
ent from all other validation studies, could suggest the good 
functionality of the PDI for detecting specific dimensions and 
characteristics of psychiatric disorders. In fact, all these two 
items identify problematic issues in psychiatric field: physical 
symptoms are not typical of psychiatric disorders, especially 
psychosis, which, on the contrary, are often characterized by 
the “denial of illness” or “distortion of symptoms” and the 
lack of awareness regarding disease;61 establishing therapeutic 
relationships, which is considered a “predictor of outcome” 
in psychiatric setting, is often difficult for our patients due 
to the altered relationships and social maladjustment directly 
related to many psychiatric diseases, especially in an acute 
phase of illness.62 In accordance with the earlier reported 
studies, our factor analysis suggested that the experience of 
dignity, which can be jeopardized by illness, is composed of 
three main psychological dimensions: 1) existential distress 
related to both self-identity and social role, 2) anxiety and 
uncertainty for future and 3) loss of autonomy in personal 
activities and thoughts. Moreover, our three-factor model 
was largely comparable to the three main areas first identified 
by Chochinov,36 as shown in Figure 2, indicating that, also 
in psychiatry, three psychological dimensions can condi-
tion the patient perception of dignity. From our model, we 
can infer that loss of autonomy in activities and thinking is 
closely related to illness as well as the feelings of anxiety and 
uncertainty for future, whereas the fear of losing the conti-
nuity of self and social status can constitute the core part of 
dignity. In fact, this dimension, represented by Factor 1, was 
the biggest one, loaded by the highest number of PDI items 
with the highest internal consistence in comparison with the 
other two factors, indicating that “Loss of self-identity and 
social role” was the most potentially detrimental dimen-
sions for dignity, closely followed by “Anxiety and uncer-
tainty about the future” and “Loss of personal autonomy”. 
We hypothesize that, especially in the most severe diseases, 
both the continuity of self and social status of individuals 
can be undermine, inducing feelings of hopelessness and 
helplessness and fear of dependency, which, all together, 
can strongly compromise personal and social dignity. Our 
study as well as other research among patients affected by 
different pathologies42,43 suggest the specificity of the PDI in 
detecting the universality of dignity that can be interpreted 
as a sort of “interface” between patients and others altered 
Table 7 Correlations of PDI and the three factors identified with other scales
Scales PDI  
(m=48.27±19.59 SD)
Factor 1  
(m=21.37±9.79 SD)
Factor 2  
(m=14.59±6.72 SD)
Factor 3  
(m=4.76±2.73 SD)
ham-D (m ±	sD)
14.20±7.58 spearman’s rho =0.33 
(P=0.0005)
Kendall’s score =1,259 
(P=0.005)
spearman’s rho =0.28 
(P=0.0034)
Kendall’s score =1,021 
(P=0.0046)
spearman’s rho =0.28 
(P=0.0032)
Kendall’s score =1,077 
(P=0.0028)
spearman’s rho =0.31 
(P=0.0011)
Kendall’s score =1,062 
(P=0.0015)
ham-a (m ±	sD)
9.90±6.70 spearman’s rho =0.3075 
(P=0.0014)
Kendall’s score =1,156 
(P=0.0013)
spearman’s rho =0.28 
(P=0.0036)
Kendall’s score =1,029 
(P=0.0043)
spearman’s rho =0.26 
(P=0.0069)
Kendall’s score =970 
(P=0.007)
spearman’s rho =0.23 
(P=0.0203)
Kendall’s score =1,080 
(P=0.0027)
Abbreviations: PDi, Patient Dignity inventory; m, mean; sD, standard deviation; ham-D, hamilton rating scale for Depression; ham-a, hamilton anxiety rating scale.
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by regressive and disruptive illness conditions. This result 
was further confirmed by the positive correlation of the PDI 
and the three-factor scores with the depression and anxiety 
scale scores, indicating that the areas investigated were 
largely although not completely overlapped. This significant 
correlation provided concurrent validity of the PDI applied 
to psychiatry. In this regard, in line with another study,41 
we highlighted that patients showed worsened perception 
of dignity when they felt anxious and depressed, symptoms 
conditioned by many kinds of severe and disabling illnesses, 
including psychiatric disorders. We have to underline that, in 
most of our cases, “anxiety and uncertainty for future” were 
not related only to depressive disorders, since our patients 
suffered from many different psychiatric diseases. In this 
regard, we can infer that these symptoms were related not 
only to a specific diagnosis but also to the condition of hos-
pitalization, which, even if necessary, can potentially induce 
a dramatic disruption of previous living habits and can lead 
the patients to be dramatically aware of their inability to live 
independently. Hospitalization can represent a deprivation 
of patients’ liberty and privacy since they have to adhere 
to pre-defined therapeutic activities, to share spaces with 
others and to be subject to ward rules, especially in case 
of involuntary admission.20,21,35 Nevertheless, these same 
restrictive conditions can incentivize cooperation with pro-
fessionals and favor the recovery process.
Our preliminary investigation highlights that PDI was 
easy to administer for professionals and to understand for 
patients, regardless of their education level and disabilities. 
It was a useful tool to quantify the patients’ subjective 
experience of hospitalization and treatment, providing their 
personal feedback. Among our patients, the PDI was gener-
ally well appreciated, probably because it was seen as a sign 
of professionals’ interest in their problems. This observation 
indicates that the PDI can be useful to improve therapeutic 
relationship and increase patients’ adherence to treatments 
and, indirectly, the positive outcome of treatments.19,21 
According to our research, PDI can represent a useful tool 
for both professionals and patients, permitting us to reflect 
on the health care provided and, in the meantime, improving 
the ethical aspects of the therapeutic relationship. Therefore, 
we can suggest to implement it at discharge of hospitalization 
as a feedback of caring and treatment, in order to promote 
the improvement of the quality of care.
Moreover, the questionnaire allows us to focus our atten-
tion on the concept of dignity in psychopathological context, 
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Figure 2 Plot of the correspondence between the three factors identified and the three Chochinov’s macro­areas.
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indicating that, also in this field, more than one dimension 
contributes to forming its personal experience, in analogy to 
the historical and philosophical concept of dignity. In light 
of our results, we suggest that dignity can be the resultant of 
many overlapped factors belonging to both the internal and 
the external world of patients.
study limitations
The first limitation of the study is represented by the rela-
tively limited sample size, even if sufficiently adequate to 
perform the factor analysis according to the index of KMO 
described earlier. Another limitation can be constituted by 
the heterogeneity of psychiatric disorders in our sample as 
well as the time of PDI administration just before discharge 
that could have conditioned our outcome. We must empha-
size that this is a preliminary study, aimed at the initial 
administration and validation of the PDI in a psychiatric 
setting. Additional research on a larger number of patients, 
among other psychiatric settings, such as facilities for dis-
abling disorders, for example, is necessary in order to confirm 
the validation of PDI and to analyze the predictive validity 
of PDI among psychiatric patients.
Conclusion
Our survey suggests that the PDI can be a reliable and valuable 
tool to measure the subjective perception of dignity among 
patients admitted to the psychiatric ward, until now little 
investigated. From our factor analysis, we suggest that the 
perception of dignity is impacted by various psychological 
dimensions related to the areas of self and relationships with 
others, which can be strongly disrupted by severe and dis-
abling illness conditions, including psychiatric diseases.
The PDI was well accepted by our patients, who 
responded with excellent participation, demonstrating a cor-
rect understanding of the questionnaire and the underlining 
concept of dignity. Its easy administration and compilation 
can be a further incentive to promote it in psychiatry to 
improve therapeutic relationship and indirectly the outcome 
of treatment.
We conclude by saying that care and cure without dignity 
cannot be effective, especially in psychiatry, where prejudice 
and stigma are still the major obstacles to understanding 
patients and fostering their full social reintegration.
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